COVID-19: First SARS-CoV-2 neutralizing antibody discovered

May 07, 2020 – YUMAB’s human SARS-CoV-2 antibody candidate exhibits a coronavirus neutralizing effect, as confirmed in preclinical tests with COVID-19 patient sera at the Helmholtz Center for Infection Research. In addition, another round of several hundred antibodies is currently being screened while YUMAB coordinates the next steps with partners and regulatory bodies towards clinical development.

Read YUMAB’s press release (English)
Read YUMAB’s press release (German)